Entries by retinalconsultants

Implantable Telescope Technology Now Available in Phoenix

NEW YEAR BRINGS SIGHT RESTORING “IMPLANTABLE TELESCOPE” TECHNOLOGY TO ARIZONA PATIENTS WITH END-STAGE AGE-RELATED MACULAR DEGENERATION PHOENIX-BASED RETINAL CONSULTANTS OF ARIZONA JOINS PATIENT CARE TEAM January 7, 2015 – Phoenix, AZ – Retinal Consultants of Arizona (RCA) – one of the nation’s leading Retina & Vitreous clinical research and patient treatment facilities – is proud […]

Dr. Matthew Witmer & A Patient Letter of Restored Vision

Dr. Matthew Witmer Receives Patient Letter of Appreciation for Restored Vision Dear Staff of Retinal Consultants of Arizona, I just wanted to drop you a note and tell you how good a surgeon you have. I saw Dr. Witmer in October to have some floaters removed from my left eye. He did the surgery and […]

RCA Recognized for Excellence in Healthcare

The United States Trade and Commerce Institute Recognize Retinal Consultants of Arizona for Excellence in Healthcare Retinal Consultants of Arizona (RCA) – one of Arizona’s leading Retina and Vitreous medical practices received recognized for Excellence in Healthcare from the United States Trade and Commerce Institute. “We are proud to be recognized by the USTCRI for […]

Anti-PDGF, anti-VEGF combination may be game changer in wet AMD treatment

“Anti-VEGF monotherapy will go down in medical history as a treatment model that was both insurmountable and unsustainable.” “It was insurmountable because of the historic gains that were seen in a disease, neovascular macular degeneration, that had miserable treatment results earlier. We went from essentially not being able to treat our patients at all and […]

Dr. Matthew Witmer: An Early Holiday Gift of Kindness

To: Dr. Matthew Witmer & Retinal Consultants of Arizona While on my way to my eye appointment yesterday I happened to think of the many time folks have come up to my husband, a retired Marine, to thank him for his service. Then my thoughts turned to Dr. Witmer and the many hours of studying, […]

Combination therapy offers improved visual outcome compared with anti-VEGF monotherapy, trial finds

“Use of a novel anti-platelet-derived growth factor therapy in concert with ranibizumab resulted in a statistically significant improvement in visual outcome vs. ranibizumab monotherapy for the treatment of wet age-related macular degeneration, according to a press release from Ophthotech…” Retinal Consultants of AZ is committed to clinical research and the pursuit of new and improved […]

Anti-PDGF Combination Agent More Effective Than Ranibizumab Monotherapy for Wet AMD

“The anti-platelet derived growth factor (PDGF) combination agent Fovista (Ophthotech Corp.) showed statistically significant superior efficacy over ranibizumab (Lucentis, Genentech) monotherapy for the treatment of wet AMD, according to the results of a phase 2b study, which were recently reported in an Ophthotech release…” Retinal Consultants of AZ is committed to clinical research and the […]